Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 203

BMW picks competition winner

BMW will double the prize money awarded to winners of New York City's BigApps 2.0 event

Mar 27, 2011

SVB finds the Color is green

Color raises $41m in green dollar bills from venture capital firms Bain Capital Ventures and Sequoia Capital and debt and equity provider Silicon Valley Bank.

Mar 25, 2011

Glam Media adds BBS Media

Mark Boxer and Brian Fields, BBS Media's co-founders, will serve as vice-presidents of Glam Media Canada and in charge of publisher and brand-advertising sales.

Mar 20, 2011

Veolia accelerates innovation partnering

Veolia Innovation Accelerator has partnered five companies, including Envolure, a France-based environmental analysis maker, software company Cosmo, Canada-based Ostara Nutrient Recovery Technologies, GreenRoad, a US fuel-saving start-up, and Advanced Cyclone Systems, a Portugual-based company to filter industrial pollutants.

Mar 20, 2011

Comcast joins SeedStart Media 2011

New York City-based SeedStart Media 2011 is a summer programme for start-up companies in digital content, e-commerce, advertising infrastructure and mobile technology.

Mar 6, 2011

Saint-Gobain picks three winners

The winners of Saint-Gobain's third global innovation competition will also work with its Nova External Venturing team.

Mar 1, 2011

Citrix accelerates first venture

Citrix Startup Accelerator has invested an undisclosed sum in Primadesk, a service to help users search, manage and backup their personal cloud data.

Mar 1, 2011

Laing builds on Novacem deal

A series A round is expected by mid-2011, Novacem said, after UK-based construction company Laing O'Rourke joins a $3m seed round.

Feb 23, 2011

Novo seeds Orphazyme Aps

Joining Henrijette Richter, investment director at Novo, in the seed round is venture capital firm Sunstone Capital.

Feb 19, 2011

Cleveland Clinic backs SironRX

SironRX spun out from Juventas Therapeutics and licenses products from its parent and Cleveland Clinic and will use the $500,000 seed money to initiate a phase II clinical study of its lead product.

Feb 11, 2011
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here